12月10日,新动能基金公司投资企业上海宝济药业(02659.HK)在香港联合交易所主板挂牌上市,发行价26.38港元,首日股价暴涨139%,市值突破205亿港元,成为2025年港股第23家上市的医药企业,也成为公司收获的第116家投资上市企业。宝济药业成立于2019年,是一家临床和商业化阶段的生物医药公司,主要从事研发和生产重组生物药。其核心产品布局大容量皮下给药、自身免疫性疾病、辅助生殖以及...
Source Link12月10日,新动能基金公司投资企业上海宝济药业(02659.HK)在香港联合交易所主板挂牌上市,发行价26.38港元,首日股价暴涨139%,市值突破205亿港元,成为2025年港股第23家上市的医药企业,也成为公司收获的第116家投资上市企业。宝济药业成立于2019年,是一家临床和商业化阶段的生物医药公司,主要从事研发和生产重组生物药。其核心产品布局大容量皮下给药、自身免疫性疾病、辅助生殖以及...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.